Recognising and Treating the Diabetic Patient in Cardiovascular Care (Q35586294)

9 August 2017

1 reference

title

Recognising and treating the diabetic patient in cardiovascular care (English)

1 reference

9 August 2017

Recognising and Treating the Diabetic Patient in Cardiovascular Care (English)

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)00034-8

Cardiology and cardiovascular medicine

2 April 2024

main subject

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)00034-8

2 April 2024

author name string

Malgorzata Bartnik

series ordinal

1

1 reference

9 August 2017

Klas Malmberg

series ordinal

2

1 reference

9 August 2017

Lars Rydén

series ordinal

3

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14622671

2 April 2024

publication date

1 October 2002

1 reference

full work available at URL

9 August 2017

https://academic.oup.com/eurjcn/article-pdf/1/3/171/34222112/eurjcn0171.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14622671

http://journals.sagepub.com/doi/pdf/10.1016/S1474-5151(02)50034-8

2 April 2024

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)00034-8

http://journals.sagepub.com/doi/full-xml/10.1016/S1474-5151(02)50034-8

2 April 2024

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)00034-8

European Journal of Cardiovascular Nursing

2 April 2024

published in

1 reference

9 August 2017

volume

1

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

171-181

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Type 2 diabetes and macrovascular disease: epidemiology and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Impaired glucose tolerance as a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Task Force on Sudden Cardiac Death of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Diabetes and decline in heart disease mortality in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Diabetes mellitus and congestive heart failure. Further knowledge needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Screening for diabetes in an outpatient clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate) [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Aspirin Therapy in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Substantial variations in clinical outcome following hospitalization for heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-convertin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Educating Nurses and Patients to Manage Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Blood glucose and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)50034-8

7 January 2021

33

44

68

von Bibra H.

2001

1 reference

https://api.crossref.org/works/10.1016/S1474-5151(02)00034-8

2 April 2024

Identifiers

1 reference

9 August 2017

1 reference